Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc. - PEPG
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
-
Game-Changing Medical Demonstration Poised to Rewrite Theranos Story
-
Gouverneur Bancorp, Inc. Announces Semi-Annual Cash Dividend
-
embecta to Report Fiscal Second Quarter 2025 Financial Results
-
How InteroSoft Is Protecting UK Crypto Portfolios with 24/7 AI Monitoring
-
Resmed Names Salli Schwartz as Chief Investor Relations Officer
-
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ibotta, Inc of Class Action Lawsuit and Upcoming Deadlines - IBTA
-
Prospera Energy Announces Monthly Operations Update
-
VALUE LINE, INC. DIVIDEND HAS JUST BEEN RAISED FROM $1.20 TO $1.30 (ANNUALIZED) – ITS 11TH CONSECUTIVE INCREASE
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortrea Holdings Inc. - FTRE
-
Cumulus Media Announces Conference Call to Discuss First Quarter 2025 Operating Results
-
Older Americans’ Services At Risk or Eliminated in Trump Proposed Budget
-
P10 Announces Appointments of Jennifer Glassman and Stephen Blewitt to Board of Directors
-
USCB Financial Holdings, Inc. Declares Quarterly Cash Dividend on Common Stock
-
Revive Therapeutics Announces Proposed Shares for Debt Transaction
-
Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development
-
Weatherford and AIQ Sign Strategic Partnership to Accelerate Efficiency in Energy Production
-
Prison Fellowship’s Statement on the Appointment of William ‘Billy’ Marshall III as Director of Federal Bureau of Prisons
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gorilla Technology Group, Inc. - GRRR
-
Pennant Announces First Quarter 2025 Earnings Release and Call
-
TruGolf Reports 2024 Financial Results
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX
-
Pomerantz Law Firm Announces the Filing of a Class Action Against NET Power Inc. and Certain Officers – NPWR
-
Everbright Digital Holding Limited Announces Closing of Initial Public Offering
-
Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
-
Precision Optics to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
-
FreightCar America, Inc. To Release First Quarter 2025 Results On May 5, 2025
-
Fabrinet to Announce Third Quarter Fiscal Year 2025 Financial Results on May 5, 2025
-
Middlesex Water Company to Report First Quarter 2025 Earnings on May 1
-
Royalty Pharma Declares Second Quarter 2025 Dividend
-
Meiwu Technology Company Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
-
ESCO Technologies Announces Second Quarter 2025 Earnings Release and Conference Call
-
DraftKings to Release First Quarter 2025 Results on May 8, 2025 and Host Conference Call on May 9, 2025
-
Postal Realty Trust, Inc. to Report First Quarter 2025 Financial Results on April 30, 2025
-
First Financial Northwest, Inc. Announces Declaration of Initial Liquidating Distribution; Stock Transfer Books Closed
-
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
-
LifeStance to Host First Quarter 2025 Earnings Conference Call on May 7, 2025
-
Bringing clarity and precision to the cell-free space by introducing exozymes
-
Galapagos Announces Executive Leadership Updates
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Methanex Corporation - MEOH
-
Shenandoah Telecommunications Company to Hold its First Quarter 2025 Earnings Call at 8:30 a.m. on Wednesday, April 30, 2025
-
Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio
-
Clover Health to Participate in Upcoming Investor Conferences
-
NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism
-
AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer
-
CarGurus To Report First Quarter 2025 Financial Results
-
Tactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025
-
Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025
-
Kaltura to Announce Financial Results for First Quarter 2025 on Thursday, May 8, 2025

